PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

Conditions:   Carcinoma, Non-Small-Cell Lung;   Immune-Related Adverse Events Interventions:   Drug: PD-1 inhibitor;   Drug: Chemotherapy Drugs, Cancer Sponsors:   Sungkyunkwan University;   Ministry of Food and Drug Safety, Korea Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials